Junction plakoglobin (JUP) is a critical cell adhesion molecule implicated in mediating cell-cell adhesion. Cancer, characterized by the loss of normal cellular regulation, results in unchecked proliferation and the breakdown of cell-cell junctions, facilitating malignant cell invasion into surrounding tissues. Recent studies have highlighted the involvement of JUP in the transduction of various intercellular signaling pathways, underscoring its significant role in tumor initiation, progression, and prognosis. In contrast to its homolog β-catenin, the interplay between JUP and cancer remains underexplored. To clarify JUP’s role and underlying mechanisms in cancer progression, this review examines recent advancements, focusing on JUP’s regulation of key cancer-related signaling pathways, such as Wnt/β-catenin, p53, and cadherin-mediated pathways. The review also investigates JUP’s relevance across various cancer types, including those of the reproductive, digestive, and urinary systems. Mechanistically, JUP exhibits context-dependent actions in different cancers, demonstrating dual roles in tumorigenesis. Lastly, the potential of JUP as a target for early diagnosis, effective treatment, and prognostic prediction in cancer is evaluated. In conclusion, targeting JUP offers a promising avenue for cancer therapy, providing valuable insights for future research.

Background: Acinar-to-ductal metaplasia (ADM) is a pivotal step in pancreatic tumorigenesis, reversible in normal contexts but progressing to PanIN and pancreatic cancer (PC) in the presence of Kras mutation and inflammation. Thus, delineating exocrine cell heterogeneity and identifying regulators of ADM are essential for understanding pancreatic tumorigenesis. Methods: We collected single-cell RNA sequencing (scRNA-seq) data of 146 human pancreatic samples, followed by comprehensive exploration of dynamic change and heterogeneity of ADM via machine learning algorithms. Multi-omics analysis integrating ATAC-seq and RNA-seq highlights the association of Klf4-Tymp axis with ADM. A dual-luciferase reporter assay was performed to evaluate the transcriptional activation of the Tymp promoter by Klf4. AAV-mediated gene silencing was performed in vivo to elucidate the roles and underlying mechanisms of the Klf4/Tymp axis during the ADM process in Pdx1-Cre; Kras ^G12D/+ (KC) mice. In-vitro mouse pancreatic organoid model combined with amino acid mutation was established to investigate the role of Tymp in regulating ADM and its underlying mechanisms. Results: scRNA-seq revealed one S100A4 ⁺ acinar subpopulation and six ductal subpopulations (GPX1 ⁺ , CD24 ⁺ , TFF3 ⁺ , MT-ATP8 ⁺ , S100A9 ⁺ , and HMGB2 ⁺ ) associated with poor prognosis in PC. Integrated pseudotime analysis of pancreatic acinar and ductal cells highlighted the potential involvement of TYMP in regulating the pathological process of ADM. Klf4 was identified as an upstream transcription factor regulating the Tymp gene. ATAC-seq revealed increased chromatin accessibility at the Klf4 and Tymp locus under inflammatory injury or oncogenic Kras conditions. Dual-luciferase reporter assays demonstrated that the transcription factor Klf4 binds to the promoter region of Tymp, thereby promoting its transcriptional expression. Pancreatic overexpression of Klf4 in mice upregulated Tymp expression and facilitated inflammation-induced initiation and progression of ADM. Exogenous supplementation with Tipiracil Hydrochloride suppressed the effects induced by Klf4. Knockdown of the Tymp gene suppressed inflammation-driven initiation and progression of ADM in KC mice through Pi3k/Akt and Mek/Erk pathways. Conclusions: The Klf4-Tymp axis promotes inflammation-associated early pancreatic tumorigenesis by enhancing KRAS mutation-induced ADM through activation of the Pi3k/Akt and Mek/Erk signaling pathways. These findings provide new insights into the molecular mechanisms linking inflammatory injury to ADM and early pancreatic tumorigenesis.

Immune checkpoint inhibitors have transformed cancer treatment, but responses remain limited in many advanced solid tumors, especially immunologically R

Pyroptosis is a gasdermin (GSDM)-mediated lytic form of regulated cell death (RCD) that can either enhance antitumor immunity or maintain tumor-promoting i